Back to Journals » Drug, Healthcare and Patient Safety » Volume 10

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]

Total article views   Abstract views HTML views PDF downloads Totals
1,214 Dovepress* 968 113+ 415 1,081
PubMed Central* 0 133 62 133
Totals 968 246 477 1,214
*Since 16 July 2018
+Since July 2016

View citations on PubMed Central and Google Scholar